RNF13 and pancreatic ductal adenocarcinoma: A study that included 72 pancreatic ductal adenocarcinoma (PDAC) patients showed that RNF13 was overexpressed in 30 tumor samples, and its expression was significantly associated with histological grading (Zhang et al., 2009).